CRC ORE
Grade Engineering is an approach focussed on early liberation of ore from waste working towards the ultimate vision of in-situ extraction. IES is a cllaborative multi-year program to build the next generation of metallurgical simulation platform.
Ms Suzi Moore
Communications CoordinatorMs Clytie Dangar
General Manager, Stakeholder EngagementCSIRO
Ms Sarah Spencer
Investment Portfolio CoordinatorMs Christine Emmanuel
Executive Manager, Intellectual Property, Licence and Investment PortfolioMrs May Ling Goode
Investment Portfolio CoordinatorCTx CRC Ltd
Cancer Therapeutics CRC (CTx) is in the business of finding cures for cancer. It was founded in 2007 and received an initial seven years of funding from the Cooperative Research Centre (CRC) Programme. It is a collaborative partnership of leading research institutes, universities and commercial enterprises that translates Australia’s innovative research discoveries into new cancer drugs ready for clinical development.
Mr Brett Carter
Chief Operating OfficerDr Michelle Zajac
Director of Research & Alliance ManagementDepartment of Industry, Innovation and Science
Mr Damien Ellwood
Assistant Manager Growth Centre PolicyMr Mark Weaver
Digital Health CRC
Mrs Elizabeth Foley
Establishment ManagerMr David Jonas
CEOMrs Lee-Ann Breger
Head of Partner Relations and Program OfficerDomainex
Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally. Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of clients across the world including Auspherix, UCB, FORMA Therapeutics, St George’s University and The Institute of Cancer Research. Our expertise and commitment to providing high quality services has resulted in a strong success record in drug discovery, delivering an average one candidate drug every year for the past six years.
Domainex’s highly experienced molecular biologists, assay biologists, medicinal, computational and analytical chemists can be leveraged through our CRO services. Domainex’s focus is on providing highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of drug targets. Whether your project is at an early stage of drug discovery or has already identified chemical matter, our processes have been shown to result in a 30% time-saving compared to industry standards and use less resource, allowing prudent management of your own budget.
Dr Tifelle Reisinger
Head of Business Development, Asia PacificDST Group
Mr Simon Martinovic
Deputy Director Strategic EngagementDr Craig Rogers
A/Director Industry EngagementMr Jamie Watson
Innovatorebilities
ebilities, the trading name of Lewis Cadman Consulting, is an Australian technology company who have designed, researched and developed an innovative range of online mental agility tests. These world leading tests are designed for use anywhere in the world to identify high potential candidates with the learning agility and problem solving skills needed for success in 21st century workplaces, and the confidence in their abilities to make timely decisions without the 'derailing' influence of overconfidence or underconfidence.
ebilities have constructed their short, sharp tests from the ground up for use in both established and emerging markets, for both small scale and mass recruitment. They are available in a number of languages, and can be taken on computers, tablets or mobile devices.